Navigation Links
AlphaVax Announces Promising Results in Melanoma Studies
Date:5/13/2009

RESEARCH TRIANGLE PARK, N.C., May 13 /PRNewswire/ -- AlphaVax announced today the presentation of promising results from a collaboration with researchers at the Memorial Sloan-Kettering Cancer Center (MSKCC). Francesca Avogadri, Ph.D., a Research Fellow in the Department of Medicine at MSKCC presented data at the American Association of Immunologists Annual Meeting in Seattle, Washington.

Results from pre-clinical studies conducted at MSKCC demonstrate the ability of AlphaVax's virus-like replicon vector particles (VRP) encoding melanoma-specific tumor antigens to reduce melanoma tumor burden in a state-of-the-art murine melanoma model.

Jedd D. Wolchok, M.D., Ph.D., Lab Head and faculty member at MSKCC, is a medical oncologist who specializes in the treatment of melanoma and in whose laboratory the work was conducted. Dr. Wolchok's research is focused on harnessing the immune system to prevent melanoma from recurring after surgery, as well as more effective treatments for the disease when it does recur. In comparing these results to others that his lab has investigated, Dr. Wolchok commented that "this is the most potent single intervention we have seen in this model."

"We are excited by the results obtained in the studies conducted by Dr. Wolchok's group at MSKCC. Immunotherapeutic intervention with a novel vaccine vector such as ours may prove beneficial as a treatment strategy for patients with melanoma, and we hope to translate these findings into clinical testing in the near future," said Robert Olmsted, Ph.D., Vice President of Research at AlphaVax, Inc.

The American Cancer Society estimates that nearly 62,500 people were diagnosed with melanoma of the skin in 2008, and over 8,400 deaths were due to the disease. While melanoma accounts for a small percent of all skin cancers, it is far more serious than other skin cancers if not detected and treated early. Melanoma is a form of cancer
'/>"/>

SOURCE AlphaVax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AlphaVax Announces Results From Phase 1 Influenza Vaccine Clinical Trial
2. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
3. AlphaVax Continues to Expand the Use of Its Vaccine Platform
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... and LONDON , December 24, ... industry are expected to grow at an average rate ... of value and volume. Hip, knee and spine surgeries ... while in emerging economies they have a lower penetration. ... challenging the use of composites. Non-metallic orthopedic devices have ...
(Date:12/24/2014)... DALLAS , December 24, 2014 /PRNewswire/ ... Research Report on Global Disposable Syringe Industry ... to its online business intelligence library. ... Global Disposable Syringe Industry is a professional ... Syringe market.  For overview analysis, the report ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... SPRINGS, Fla., Oct. 8 The most comprehensive, ... and regulations is now available from Point of ... information technology (HIT) strategy and management consulting firm ... health records, health information exchanges and personal health ...
... Millennium Research Group (MRG), the global authority on medical ... surgical lights will represent 100% of surgical light sales ... longer lasting LED lights. MRG,s European Markets for ... report finds that adoption will be accelerated in Europe, ...
Cached Medicine Technology:Newly Updated Pharmacy State Law Compendium Available 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 3
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter ... news about the experimental Ebola vaccine that U.S. officials are ... shows a precursor of that vaccine produced a safe and ... the vaccine, when given to more than 100 Ugandans in ... blood cells that could potentially protect a person against infection ...
(Date:12/24/2014)... -- Longer and colder body cooling does not reduce the ... a lack of oxygen, a new study finds. The ... -- called hypoxic ischemic encephalopathy -- can be reduced by ... for 72 hours, experts say. Research has shown that ... this study examined if the same would be true in ...
(Date:12/24/2014)... News) -- Though most patients with obsessive-compulsive disorder (OCD) ... 10 percent to 20 percent have a form of ... say. However, patients with this so-called "refractory OCD" ... of brain surgery that disables certain brain networks believed ... between patients most likely to benefit from the surgery, ...
(Date:12/24/2014)... TUESDAY, Dec. 23, 2014 (HealthDay News) -- If you ... off if you are not treated by a cardiologist, ... actually improved when cardiologists left town for annual professional ... with cardiac arrest who were admitted to a teaching ... days, but 70 percent died when these meetings were ...
(Date:12/22/2014)... December 22, 2014 As part ... senior care service in San Diego and ... of its senior care team with ongoing online ... Golden Care is provided by Caregiverlist®. Caregiverlist® ... caregivers with the most reliable eldercare options, highest ...
Breaking Medicine News(10 mins):Health News:Early Study Offers Hope for an Ebola Vaccine 2Health News:Early Study Offers Hope for an Ebola Vaccine 3Health News:Early Study Offers Hope for an Ebola Vaccine 4Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2Health News:Scans May Spot People Who'll Benefit From Surgery for OCD 2Health News:When Heart Docs Are Away, Their High-Risk Patients May Fare Better 2Health News:When Heart Docs Are Away, Their High-Risk Patients May Fare Better 3Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2
... The Madras Institute of Trauma (MIOT) deserves to be called ... minimally invasive surgery (MIS) for all kinds of surgeries. // ... that provides 40 fold magnification of a specific body ... liver, cardiac bypass, surgical excision of brain tumor, spinal injury ...
... cell research in the state with the approval of 61% ... have impeded the initiative. // ,The officials now ... will be initiated. Zach Hall, president of the California Institute ... would commence the project as soon as possible. ...
... head of Psycho and Geriatrics Ward at the Punjab Institute of ... their relatives after they have been declared mentally fit by doctors. ... such patients who have completely recovered but no place to go. ... members they say that these patients are of no use and ...
... rushing off at lunch breaks, coughing up ?4,500 for Jiffy ... for such breast implant operations//, and is getting into the ... Kirkham was one of the first to be on their ... by her mom and a student loan. She said: ...
... buster, pain reliever, sleep-inducer, hair conditioner and wrinkle remover, ... guessing! Intimate sex with your partner can provide the much ... NHS helpline says "Forget about jogging round the block or ... fact, good bout of 'sexercise'." ,The NHS site ...
... has spent the last two decades in chains in a ... Pradesh//. His family said that Mansharam did not move at ... ,His brother Bhogchand says that Mansharam was chained to a ... "We spent a lot of money to get him treated ...
Cached Medicine News:Health News:Any Form Of Minimally Invasive Surgery- Name It & They Do It! 2Health News:Momentum of Stem cell research impeded by legal challenges 2Health News:Is mental illness a social stigma? 2
... pacemaker family, which includes the world's ... the most advanced pacemaker technology available, ... the first and only U.S. commercially ... fibrillation (AF). The AF Suppression algorithm ...
... the real-time monitoring surveillance of a ... tools. Moreover, the Information Center is ... so that monitoring data can be ... radiology images, archived data, lab results, ...
... system uses catheters that are controlled ... console. The console processes the refrigerant, ... tip of the catheter, creates cryogenic ... an easy-to-use touch-screen interface. From this ...
... tasks and delivers consistently reliable ... and ensure testing accuracy in ... automated reticulocyte counts and three-dimensional ... sensitivity, specificity and efficiency in ...
Medicine Products: